H.R. 6000 117th Congress House

Cures 2.0 Act

Official title: To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes.

Introduced: January 13, 2022 Introduced by: Diana DeGette Democratic · Colorado See on congress.gov

Health Administrative law and regulatory proceduresAdministrative remediesAdvisory bodiesAppropriations

More subjectsShow fewer subjects

Cardiovascular and respiratory healthCell biology and embryologyCenters for Disease Control and Prevention (CDC)Child care and developmentChild healthComputers and information technologyCongressional oversightDepartment of Health and Human ServicesDigestive and metabolic diseasesDigital mediaDrug safety, medical device, and laboratory regulationDrug therapyEconomic performance and conditionsEducation programs fundingEmergency medical services and trauma careExecutive agency funding and structureFederal officialsFood and Drug Administration (FDA)GeneticsGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth facilities and institutionsHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHereditary and development disordersHigher educationHome and outpatient careHospital careImmunology and vaccinationIndian social and development programsInfectious and parasitic diseasesIntergovernmental relationsInternet and video servicesInternet, web applications, social mediaLicensing and registrationsLong-term, rehabilitative, and terminal careManufacturingMedicaidMedical educationMedical researchMedical tests and diagnostic methodsMedicareMilitary medicineMinority healthNational Institutes of Health (NIH)Poverty and welfare assistancePreschool educationPrescription drugsPublic contracts and procurementResearch administration and fundingRight of privacyState and local government operationsStudent aid and college costsUser charges and feesVeterans' medical careWorld health

Everywhere this bill has been 8 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jan 4, 2022

Referred to the Subcommittee on Biotechnology, Horticulture, and Research.

Dec 7, 2021

Referred to the Subcommittee on Health.

Dec 2, 2021

Referred to the Subcommittee for Indigenous Peoples of the United States.

Nov 18, 2021

Referred to the Subcommittee on Health.

Nov 18, 2021

Referred to the Subcommittee on Oversight, Management, and Accountability.

Nov 17, 2021

Referred to the Subcommittee on Health.

Nov 17, 2021

Introduced in House

Nov 17, 2021

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Budget, Science, Space, and Technology, Agriculture, Education and Labor, Armed Services, Natural Resources, Veterans' Affairs, Homeland Security, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Latest action January 4, 2022

Referred to the Subcommittee on Biotechnology, Horticulture, and Research.

Plain-English summary Congressional Research Service

Cures 2.0 Act

This bill addresses pandemic preparedness and public health issues, caregiver and patient engagement, drug development, insurance coverage, and biomedical research.

The Department of Health and Human Services (HHS) must undertake research and other activities concerning COVID-19 and develop a strategy for future pandemics and declared emergencies. Additionally, the bill specifies actions to combat antimicrobial resistance.

HHS may award grants for caregiver training. The bill also addresses diversity in clinical trials, collecting patient experience data during clinical trials, and coverage for care related to participation in specified clinical trials.

The bill modifies the timeframe and requires additional guidance relating to expedited approval of certain breakthrough drugs, devices, or products. It also establishes two intercenter institutes within the Food and Drug Administration (FDA) focused on particular diseases that meet specified criteria.

The bill also addresses (1) coverage in Medicare, Medicaid, and the Children's Health Insurance Program for telehealth, genetic and genomic testing, and other services; (2) electronic prescribing standards for Medicare drug benefits; and (3) access to Medicare and Medicaid claims data by certain registries. Furthermore, the bill prohibits the use of geographic tracking or biometrics in Medicaid electronic visit verification systems.

The bill establishes the Advanced Research Projects Agency for Health (ARPA-H) within the National Institutes of Health to accelerate biomedical research and innovation through grants, contracts, cash prizes, and other means. The FDA may work with ARPA-H to expedite the development of medical products through specified activities.

Related & companion bills 7